No abstract available
MeSH terms
-
Administration, Oral
-
Cost-Benefit Analysis
-
Diabetes Mellitus / drug therapy*
-
Diabetes Mellitus / economics
-
Diabetes Mellitus, Type 2 / drug therapy*
-
Diabetes Mellitus, Type 2 / economics
-
Drug Industry / economics*
-
Drug Industry / trends
-
Humans
-
Hypoglycemic Agents / administration & dosage
-
Hypoglycemic Agents / economics*
-
Hypoglycemic Agents / therapeutic use
-
Injections
-
Insulin / administration & dosage
-
Insulin / economics*
-
Insulin / therapeutic use
-
Marketing*
-
Metabolic Syndrome / diagnosis
-
Metabolic Syndrome / drug therapy
Substances
-
Hypoglycemic Agents
-
Insulin